Literature DB >> 24701707

ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.

Michele Y Halyard, Eleanor E R Harris, Lisa Bailey, Jennifer R Bellon, Gary M Freedman, Sharad Goyal, Kathleen C Horst, Meena S Moran, Catherine C Park, W Warren Suh, Deborah Toppmeyer, Bruce G Haffty.   

Abstract

Although both breast-conserving surgery and mastectomy generally provide excellent local-regional control of breast cancer, local-regional recurrence (LRR) does occur. Predictors for LRR include patient, tumor, and treatment-related factors. Salvage after LRR includes coordination of available modalities, including surgery, radiation, chemotherapy, and hormonal therapy, depending on the clinical scenario. Management recommendations for breast cancer LRR, including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel.The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Entities:  

Mesh:

Year:  2014        PMID: 24701707

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  3 in total

1.  Proton Reirradiation for Locoregionally Recurrent Breast Cancer.

Authors:  Michael J LaRiviere; Alexandra Dreyfuss; Neil K Taunk; Gary M Freedman
Journal:  Adv Radiat Oncol       Date:  2021-05-09

2.  A genomic ruler to assess oncogenic transition between breast tumor and stroma.

Authors:  Shubhada Dhage; Amanda Ernlund; Kelly Ruggles; Deborah Axelrod; Russell Berman; Daniel Roses; Robert J Schneider
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

3.  Unresectable bulky chest wall recurrent breast cancer controlled with CT-guided interstitial high-dose-rate brachytherapy and external beam radiotherapy with adjuvant hormonal therapy - case report.

Authors:  Hiroaki Kunogi; I-Chow Hsu; Keisuke Sasai
Journal:  J Contemp Brachytherapy       Date:  2021-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.